Literature DB >> 28191595

CT-guided percutaneous screw fixation plus cementoplasty in the treatment of painful bone metastases with fractures or a high risk of pathological fracture.

Claudio Pusceddu1, Alessandro Fancellu2, Nicola Ballicu3, Rosa Maria Fele3, Barbara Sotgia3, Luca Melis3.   

Abstract

OBJECTIVE: To evaluate the feasibility and effectiveness of computed tomography (CT)-guided percutaneous screw fixation plus cementoplasty (PSFPC), for either treatment of painful metastatic fractures or prevention of pathological fractures, in patients who are not candidates for surgical stabilization.
MATERIALS AND METHODS: Twenty-seven patients with 34 metastatic bone lesions underwent CT-guided PSFPC. Bone metastases were located in the vertebral column, femur, and pelvis. The primary end point was the evaluation of feasibility and complications of the procedure, in addition to the length of hospital stay. Pain severity was estimated before treatment and 1 and 6 months after the procedure using the visual analog scale (VAS). Functional outcome was assessed by improved patient walking ability.
RESULTS: All sessions were completed and well tolerated. There were no complications related to either incorrect positioning of the screws during bone fixation or leakage of cement. All patients were able to walk within 6 h after the procedure and the average length of hospital stay was 2 days. The mean VAS score decreased from 7.1 (range, 4-9) before treatment to 1.6 (range, 0-6), 1 month after treatment, and to 1.4 (range 0-6) 6 months after treatment. Neither loosening of the screws nor additional bone fractures occurred during a median follow-up of 6 months.
CONCLUSIONS: Our results suggest that PSFPC might be a safe and effective procedure that allows the stabilization of the fracture and the prevention of pathological fractures with significant pain relief and good recovery of walking ability, although further studies are required to confirm this preliminary experience.

Entities:  

Keywords:  Bone metastases; Cementoplasty; Drill; Interventional radiology; Pathological fractures; Percutaneous screw fixation

Mesh:

Year:  2017        PMID: 28191595     DOI: 10.1007/s00256-017-2584-y

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  16 in total

1.  [Treatment outcome after surgical management of osseous breast carcinoma metastases. Preventive stabilization vs. management after pathological fracture].

Authors:  F Popken; J Schmidt; H Oegur; U J Göhring; D P König; F Braatz; M H Hackenbroch
Journal:  Unfallchirurg       Date:  2002-04       Impact factor: 1.000

2.  Cementoplasty for painful bone metastases: a series of 42 cases.

Authors:  Estelle Botton; Julien Edeline; Yan Rolland; Elodie Vauléon; Catherine Le Roux; Habiba Mesbah; Philippe Porée; Odile Audrain; Jean-Luc Raoul
Journal:  Med Oncol       Date:  2011-04-17       Impact factor: 3.064

3.  Value of percutaneous radiofrequency ablation with or without percutaneous vertebroplasty for pain relief and functional recovery in painful bone metastases.

Authors:  Frédéric Clarençon; Betty Jean; Hang-Phuong Pham; Evelyne Cormier; Gilbert Bensimon; Michèle Rose; Philippe Maksud; Jacques Chiras
Journal:  Skeletal Radiol       Date:  2011-11-13       Impact factor: 2.199

4.  Bone cement enhanced pedicle screw fixation combined with vertebroplasty for elderly patients with malignant spinal tumors.

Authors:  Jiang-wei Tan; Bing-hua Shen; Wei DU; Jiang-qing Liu; Shi-qiao Lu
Journal:  Chin Med J (Engl)       Date:  2013-07       Impact factor: 2.628

5.  Pain measurement: an overview.

Authors:  C R Chapman; K L Casey; R Dubner; K M Foley; R H Gracely; A E Reading
Journal:  Pain       Date:  1985-05       Impact factor: 6.961

6.  Retrospective analysis of factors influencing the operative result after percutaneous osteosynthesis of intracapsular femoral neck fractures.

Authors:  N W L Schep; R J Heintjes; E P Martens; L M C van Dortmont; A B van Vugt
Journal:  Injury       Date:  2004-10       Impact factor: 2.586

7.  Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up.

Authors:  A Cotten; F Dewatre; B Cortet; R Assaker; D Leblond; B Duquesnoy; P Chastanet; J Clarisse
Journal:  Radiology       Date:  1996-08       Impact factor: 11.105

8.  Metastatic disease of the femur: surgical treatment.

Authors:  William G Ward; Stephanie Holsenbeck; Frederick J Dorey; Jeff Spang; David Howe
Journal:  Clin Orthop Relat Res       Date:  2003-10       Impact factor: 4.176

9.  Mortality and complications following stabilization of femoral metastatic lesions: a population-based study of regional variation and outcome.

Authors:  Bill Ristevski; Richard J Jenkinson; David J G Stephen; Joel Finkelstein; Emil H Schemitsch; Michael D McKee; Hans J Kreder
Journal:  Can J Surg       Date:  2009-08       Impact factor: 2.089

10.  Screw placement and osteoplasty under computed tomographic-fluoroscopic guidance in a case of advanced metastatic destruction of the iliosacral joint.

Authors:  Christoph Gregor Trumm; Bianca Rubenbauer; Stefan Piltz; Maximilian F Reiser; Ralf-Thorsten Hoffmann
Journal:  Cardiovasc Intervent Radiol       Date:  2009-10-01       Impact factor: 2.740

View more
  12 in total

1.  Prophylactic Percutaneous Consolidation of Large Osteolytic Tumors of the Pelvic Ring Using Fixation by Internal Cemented Screws.

Authors:  Jessica Assouline; Lambros Tselikas; Charles Roux; Steven Yevich; Alexandre Delpla; Arash Najafi; Marc Al Ahmar; Jean-Charles Bijot; Thierry de Baère; Frédéric Deschamps
Journal:  Radiol Imaging Cancer       Date:  2021-05

Review 2.  Percutaneous Fixation by Internal Cemented Screw for the Treatment of Unstable Osseous Disease in Cancer Patients.

Authors:  Frederic Deschamps; Steven Yevich; Guillaume Gravel; Charles Roux; Antoine Hakime; Thierry de Baère; Lambros Tselikas
Journal:  Semin Intervent Radiol       Date:  2018-11-05       Impact factor: 1.513

3.  Cementoplasty of pelvic bone metastases: systematic assessment of lesion filling and other factors that could affect the clinical outcomes.

Authors:  Thomas P Moser; Marta Onate; Katia Achour; Véronique Freire
Journal:  Skeletal Radiol       Date:  2019-02-02       Impact factor: 2.199

Review 4.  Interventional Techniques for the Ablation and Augmentation of Extraspinal Lytic Bone Metastases.

Authors:  Osman Ahmed; Nicholas Feinberg; William B Lea
Journal:  Semin Intervent Radiol       Date:  2019-08-19       Impact factor: 1.513

Review 5.  Interventional Palliation of Painful Extraspinal Musculoskeletal Metastases.

Authors:  Anderanik Tomasian; Jack W Jennings
Journal:  Semin Intervent Radiol       Date:  2022-06-30       Impact factor: 1.780

Review 6.  Computer-Assisted Surgical Navigation for Primary and Metastatic Bone Malignancy of the Pelvis: Current Evidence and Future Directions.

Authors:  Alexander B Christ; Derek G Hansen; John H Healey; Nicola Fabbri
Journal:  HSS J       Date:  2021-07-07

Review 7.  Percutaneous Management of Cancer Pain.

Authors:  Dimitrios K Filippiadis; Lambros Tselikas; Alberto Bazzocchi; Evegnia Efthymiou; Alexis Kelekis; Steven Yevich
Journal:  Curr Oncol Rep       Date:  2020-04-16       Impact factor: 5.075

8.  Joint-sparing reconstruction for extensive periacetabular metastases: Literature review and a novel minimally invasive surgical technique.

Authors:  Karla Teresa S Araneta; Maroun Rizkallah; Louis-Martin Boucher; Robert E Turcotte; Ahmed Aoude
Journal:  J Bone Oncol       Date:  2022-04-06       Impact factor: 4.491

Review 9.  A practical guide for planning pelvic bone percutaneous interventions (biopsy, tumour ablation and cementoplasty).

Authors:  Marta Oñate Miranda; Thomas P Moser
Journal:  Insights Imaging       Date:  2018-03-21

Review 10.  Finite element models for fracture prevention in patients with metastatic bone disease. A literature review.

Authors:  Amelie Sas; Esther Tanck; An Sermon; G Harry van Lenthe
Journal:  Bone Rep       Date:  2020-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.